Kim 2011 |
Retrospective |
302 |
41.3 ± 7.8 |
260/42 |
Korea |
22.7 ± 2.7 |
0.7 ± 0.2 |
PTC (less than 1 cm) |
BABART |
69 |
Conventional OT |
138 |
Drainage amount, hospital days, retrieved LN number, operation time, postoperative thyroid hormone level, incidence of chyle leakage, hematoma, wound infection, permanent & transient hypocalcemia, permanent & transient VCP |
Lee 2011 |
Retrospective |
216 |
43.7 ± 7.4 |
182/20 |
Korea |
23.4 ± 3.0 |
0.82 ± 0.38 |
PTC (less than 1 cm) |
BABART |
108 |
Conventional OT |
108 |
Postoperative thyroid hormone level |
Tae 2012 |
Retrospective |
218 |
38.9 ± 10.6 |
202/16 |
Korea |
24.8 ± 4.3 |
2.24 ± 0.99 |
Benign or malignant thyroid tumor |
BABART |
113 |
BABAET |
105 |
Drainage amount, retrieved LN number, operation time, cosmetic satisfaction (3mo), incidence of hematoma, permanent & transient hypocalcemia, permanent & transient VCP |
Kim 2015 |
Retrospective |
600 |
39.5 ± 0.5 |
532/68 |
Korea |
NA |
0.60 ± 0.03 |
Well-differentiated thyroid cancers |
BABART |
300 |
Conventional OT |
300 |
Hospital days, retrieved LN number, operation time, postoperative thyroid hormone level, incidence of chyle leakage, hematoma, wound infection, permanent & transient hypocalcemia, permanent & transient VCP |
Kim 2014 |
Retrospective |
515 |
38.9 ± 10.1 |
421/94 |
Korea |
22.7 ± 3.5 |
0.78 ± 0.44 |
PTC or suspected PTC |
BABART |
123 |
Conventional OT |
392 |
Retrieved LN numbers, postoperative thyroid hormone level, incidence of permanent & transient hypocalcemia, permanent & transient VCP |
Kwak 2014 |
Retrospective |
840 |
40.01 ± 9.8 |
697/143 |
Korea |
23.14 ± 3.44 |
0.95 ± 0.76 |
PTC or suspected PTC |
BABART |
206 |
Conventional OT |
634 |
Hospital days, retrieved LN numbers, operation time, indicence of hematoma, wound infection, permanent & transient hypocalcemia, transient VCP |
Chai 2016 |
Prospective |
54 |
38.9 ± 7.5 |
54/0 |
Korea |
23.9 ± 4.0 |
0.9 ± 0.5 |
PTC |
BABART |
27 |
Conventional OT |
27 |
Hospital days, retrieved LN numbers, operation time, cosmetic satisfaction, postoperative pain score, permanent & transient hypocalcemia, permanent & transient VCP |
Cho 2016 |
Retrospective |
218 |
40.81 ± 10.84 |
185/33 |
Korea |
23.73 (17.58-33.37) |
0.7 (0.2-2.5) |
PTC |
BABART |
109 |
Conventional OT |
109 |
Hospital stay, retrieved LN numbers, postoperative thyroid hormone level, incidence of chyle leakage, hematoma, wound infection, permanent & transient hypocalcemia, permanent & transient VCP |
He 2016 |
Prospective |
100 |
40.9 ± 9.8 |
83/17 |
China |
24.9 ± 3.5 |
50.7 ± 33 |
PTC |
BABART |
50 |
Conventional OT |
50 |
Drainage amount, retreived LN numbers, operation time, cosmetic satisfaction, postoperative pain score, postoperative thyroid hormone level, incidence of chyle leakage, hematoma, wound infection, transient hypocalcemia, transient VCP |
Kim 2016 |
Retrospective |
229 |
38.9 ± 0.9 |
212/17 |
Korea |
NA |
0.50 ± 0.05 |
PTC |
BABART |
112 |
Conventional OT |
117 |
Hospital days, retrieved LN numbers, operation time, cosmetic satisfaction, postoperative pain score, postoperative thyroid hormone level, incidence of chyle leakage, hematoma, wound infection, permanent & transient hypocalcemia, permanent & transient VCP |
Paek 2016 |
Prospective |
29 |
37.0 ± 10.4 |
25/4 |
Korea |
NA |
0.81 ± 0.62 |
Well-differentiated thyroid cancers |
BABART |
15 |
Conventional OT |
14 |
Operation time, postoperative pain score |
Chai 2017 |
Retrospective |
86 |
30.8 ± 12.0 |
71/15 |
Korea |
21.0 ± 2.8 |
2.8 ± 0.6 |
Thyroid cancer (larger than 2 cm) |
BABART |
21 |
Conventional OT |
65 |
Hospital days, retrieved LN numbers, postoperative thyroid hormone level, permanent & transient hypocalcemia, permanent & transient VCP |
Chai 2018 |
Retrospective |
100 |
41.2 ± 9.4 |
93/7 |
Korea |
22.8 ± 62.6 |
1.1 ± 0.8 |
PTC, benign, or follicular neoplasm |
BABART |
50 |
TORT |
50 |
Hospital days, retrieved LN numbers, operation time, postoperative pain score (3day), incidence of wound infection, permanent & transient hypocalcemia, permanent & transient VCP |
Kim 2017 |
Retrospective |
578 |
39.6 ± 7.5 |
574/4 |
Korea |
22.2 ± 2.7 |
0.6 ± 0.3 |
PTC |
BABART |
289 |
BABAET |
289 |
Drainage amount, hospital days, retrieved LN numbers, operation time, postoperative thyroid hormone level, incidence of chyle leakage, hematoma, permanent & transient hypocalcemia, permanent & transient VCP |
Kim 2018 |
Prospective |
90 |
39.8 ± 10.7 |
83/7 |
Korea |
NA |
0.9 ± 0.5 |
PTC, benign, or follicular neoplasm |
BABART |
43 |
TORT |
47 |
Hospital days, retrieved LN numbers, operation time, cosmetic satisfaction, postoperative thyroid hormone level, incidence of chyle leakage, hematoma, permanent & transient hypocalcemia, permanent & transient VCP |
Paek 2018 |
Retrospective |
376 |
36.4 ± 9.0 |
297/79 |
Korea |
NA |
0.83 ± 0.64 |
PTC |
BABART |
71 |
Conventional OT |
305 |
Retrieved LN numbers, postoperative thyroid hormone level, incidence of chyle leakage, wound infection, permanent & transient hypocalcemia, permanent & transient VCP |
Bae 2019 |
Retrospective |
369 |
41.12 ± 8.97 |
348/21 |
Korea |
22.99 ± 3.23 |
0.78 ± 0.43 |
Differentiated thyroid cancer |
BABART |
123 |
Conventional OT |
246 |
Retrieved LN numbers, operation time, postoperative thyroid hormone level, incidence of chyle leakage, hematoma, wound Infection, permanent & transient hypocalcemia, permanent & transient VCP |
Chae 2020 |
Retrospective |
70 |
40.88 ± 9.80 |
9/61 |
Korea |
23.60 ± 4.31 |
0.75 ± 0.35 |
PTC or follicular variant of PTC |
BABART |
56 |
TORT |
14 |
Hospital days, retrieved LN number, postoperative pain score, incidence of wound infection, transient hypocalcemia, transient VCP |
Choi 2020 |
Retrospective |
1210 |
37.9 ± 10.02 |
1171/39 |
Korea |
NA |
1.45 ± 1.07 |
Benign, follicular (<5 cm), or malignant thyroid tumor |
BABART |
605 |
BABAET |
605 |
Operation time, hospital days, retrieved LN numbers, postoperative thyroid hormone level, incidence of wound infection, permanent hypocalcemia, permanent VCP |
He 2022 |
Prospective |
99 |
44.6 ± 11.8 |
21/78 |
China |
25.2 ± 14.2 |
0.35 ± 0.33 |
PTC |
BABART |
50 |
TORT |
49 |
Drainage amount, retrieved LN numbers, operation time, cosmetic satisfaction, postoperative pain score, incidence of wound infection |
Yang 2022 |
Retrospective |
564 |
40.03 ± 9.7 |
492/72 |
Korea |
23.27 ± 3.81 |
0.96 ± 0.95 |
Benign or malignant thyroid tumor |
BABART |
316 |
TORT |
248 |
Hospital days, retrieved LN numbers, postoperative pain score, incidence of chyle leakage, hematoma, wound infection, permanent & transient hypocalcemia, permanent & transient VCP |
Zhang 2023 |
Retrospective |
757 |
31.25 ± 2.07 |
680/72 |
China |
21.88 ± 0.62 |
6.3 ± 4.4 |
Benign or follicular (<5 cm), or malignant thyroid nodules at low risk |
BABART |
393 |
BABAET |
364 |
Operation time, hospital days, drainage amount, retrieved LN numbers, incidence of permanent & transient hypocalcemia, permanent & transient VCP |